Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#332 Impact of Baseline Ki-67 index and Other Baseline Characteristics on Outcome in a Study of Sunitinib (SU) for the Treatment of Advanced, Progressive Pancreatic Neuroendocrine Tumor (NET)

Introduction: Baseline Ki-67 index and other characteristics may influence outcome in patients (pts) with pancreatic NET; however, the value of Ki-67 and others have not been evaluated prospectively in trials.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Raymond E, Harmon C, Niccoli P, Metrakos P, Borbath I,

Keywords: Sunitinib, phase 3, pancreatic neuroendocrine tumor, Ki-67 index, prior treatment, prognostic factor,

#25 Predictors of response to radio-embolization (TheraSphere ®) treatment of neuro-endocrine liver metastasis

Introduction: Neuroendocrine tumors (NET) frequently metastasize to the liver. Most patients have diffuse, and therefore incurable, disease. NET liver metastasis has been shown to respond to yttrium-90 microspheres therapy. This study aims to define factors that predict response to radio-embolization in patients with NET liver metastases.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author: Metrakos P

Authors: Metrakos P, Hassanain M, Caberera T, CHaudhury P, Dumitra S,

Keywords: radio-embolization (TheraSphere ®) treatment, neuroendocrine liver metastasis, response rate, disease bulk,